759 Chestnut St, Springfield, MA 01199
Dr. Srikala Gumireddy is a endocrinology specialist in Springfield, Massachusetts.
Searching for a GLP-1 provider in your area? Our directory lists 5 verified providers serving Springfield, Massachusetts (154,888 residents · 27% adult obesity).
Each clinic below offers GLP-1 weight-loss medications including Ozempic, Wegovy, Mounjaro, and Zepbound. Compare ratings, services, and pricing — then book directly or via our partner directory at GLP1Maps.com.
759 Chestnut St, Springfield, MA 01199
Dr. Srikala Gumireddy is a endocrinology specialist in Springfield, Massachusetts.
2 Medical Center Dr, Springfield, MA 01107
Dr. Kimberly Browne-Martin, M.D. is a endocrinology specialist in Springfield, Massachusetts.
280 Chestnut St, Springfield, MA 01199
Dr. Vilma Carlone, MD is a endocrinology specialist in Springfield, Massachusetts.
280 Chestnut St Fl 2, Springfield, MA 01199
Dr. Barrett Chapin, MD is a endocrinology specialist in Springfield, Massachusetts.
2150 Main St, Springfield, MA 01104
Dr. Victoria Cook, M.D. is a endocrinology specialist in Springfield, Massachusetts.
Full directory of verified providers on GLP1Maps.com
Get an AI Receptionist that books patients 24/7 — from GLP1Receptionist.com
Read Shep's Method — patient guide to GLP-1 success at ShepsMethod.com
Independent network of GLP-1 resources serving Springfield and patients across the U.S.
Choosing the right GLP-1 provider in Springfield matters. Look for clinics that offer:
GLP-1 receptor agonists work by mimicking a hormone that regulates appetite and blood sugar. The main options:
MassHealth covers Wegovy for weight management with prior authorization.
For state regulation info, see the Massachusetts Medical Board.
Our directory lists 5 verified GLP-1 clinics in the Springfield area, with rankings based on patient reviews, services offered, and verified provider status.
MassHealth covers Wegovy for weight management with prior authorization.
Following the FDA's April 2026 503B ruling, compounded semaglutide and tirzepatide are no longer available from most U.S. pharmacies. Most clinics now prescribe FDA-approved Ozempic, Wegovy, Mounjaro, or Zepbound.